Inventor · disambiguated record
Menzo Havenga
Also filed as: HAVENGA MENZO · HAVENGA MENZO J E · HAVENGA MENZO JANS · HAVENGA MENZO JANS EMCO
33 granted patents·20 pending applications·774 citations·filing 1999–2020
98Inventor score
Files withCRUCELL HOLLAND BV28VOGELS RONALD4HAVENGA MENZO JANS EMCO2BETH ISRAEL HOSPITAL1BOUT ABRAHAM1
Top patents by PatentIndex Score
53 records- 0199US6492169B1Complementing cell linesCRUCELL HOLLAND BV·Filed 2000·Granted Dec 10, 2002·113 cites·7 claims
- 0298US7270811B2Serotype of adenovirus and uses thereofCRUCELL HOLLAND BV·Filed 2004·Granted Sep 18, 2007·112 cites·17 claims
- 0398US6913922B1Serotype of adenovirus and uses thereofCRUCELL HOLLAND BV·Filed 2000·Granted Jul 5, 2005·86 cites·19 claims
- 0497US6974695B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2001·Granted Dec 13, 2005·85 cites·22 claims
- 0596US6869794B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2002·Granted Mar 22, 2005·47 cites·13 claims
- 0695US8012467B2Multivalent vaccines comprising recombinant viral vectorsCRUCELL HOLLAND BV·Filed 2005·Granted Sep 6, 2011·18 cites·19 claims
- 0795US7906113B2Serotype of adenovirus and uses thereofCRUCELL HOLLAND BV·Filed 2006·Granted Mar 15, 2011·19 cites·11 claims
- 0895US7749493B2Chimeric adenovirusesCRUCELL HOLLAND BV·Filed 2005·Granted Jul 6, 2010·19 cites·5 claims
- 0994US8052967B2Stable adenoviral vectors and methods for propagation thereofCRUCELL HOLLAND BV·Filed 2007·Granted Nov 8, 2011·16 cites·16 claims
- 1094US7741099B2Adenoviral vectors and uses thereofBETH ISRAEL HOSPITAL·Filed 2005·Granted Jun 22, 2010·26 cites·12 claims
- 1191US7344883B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2005·Granted Mar 18, 2008·11 cites·15 claims
- 1290US7598078B2Settings for recombinant adenoviral-based vaccinesCRUCELL HOLLAND BV·Filed 2005·Granted Oct 6, 2009·13 cites·5 claims
- 1390US7285265B2Stable adenoviral vectors and methods for propagation thereofCRUCELL HOLLAND BV·Filed 2003·Granted Oct 23, 2007·25 cites·12 claims
- 1490US6905678B2Gene delivery vectors with cell type specificity for mesenchymal stem cellsCRUCELL HOLLAND BV·Filed 2001·Granted Jun 14, 2005·32 cites·12 claims
- 1589US6869936B1Means and methods for fibroblast-like or macrophage-like cell transductionCRUCELL HOLLAND BV·Filed 2000·Granted Mar 22, 2005·19 cites·2 claims
- 1688US8076131B2Settings for recombinant adenoviral-based vaccinesVOGELS RONALD·Filed 2009·Granted Dec 13, 2011·10 cites·13 claims
- 1788US7968286B2Settings for recombinant adenoviral-based vaccinesCRUCELL HOLLAND BV·Filed 2011·Granted Jun 28, 2011·11 cites·8 claims
- 1888US7604960B2Transient protein expression methodsCRUCELL HOLLAND BV·Filed 2007·Granted Oct 20, 2009·11 cites·20 claims
- 1987US8227243B2Settings for recombinant adenoviral-based vaccinesVOGELS RONALD·Filed 2011·Granted Jul 24, 2012·6 cites·14 claims
- 2087US6803234B2Gene delivery vectors with cell type specificity for primary human chondrocytesCRUCELL HOLLAND BV·Filed 2001·Granted Oct 12, 2004·13 cites·10 claims
- 2186US7235233B2Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblastsCRUCELL HOLLAND BV·Filed 2001·Granted Jun 26, 2007·11 cites·3 claims
- 2285US7816104B2Packaging cells for recombinant adenovirusCRUCELL HOLLAND BV·Filed 2006·Granted Oct 19, 2010·5 cites·18 claims
- 2383US7968087B2Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cellsCRUCELL HOLLAND BV·Filed 2009·Granted Jun 28, 2011·3 cites·5 claims
- 2482US9228205B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2014·Granted Jan 5, 2016·1 cites·15 claims
- 2582US7250293B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2002·Granted Jul 31, 2007·4 cites·17 claims
- 2681US7332337B2Viral vectors having tissue tropism for T-lymphocytes, B- and mast cellsGALAPAGOS NV·Filed 2001·Granted Feb 19, 2008·20 cites·16 claims
- 2777US7238528B2Means and methods for fibroblast-like or macrophage-like cell transductionCRUCELL HOLLAND BV·Filed 2004·Granted Jul 3, 2007·5 cites·7 claims
- 2876US8202723B2Multivalent vaccines comprising recombinant viral vectorsHAVENGA MENZO JANS EMCO·Filed 2011·Granted Jun 19, 2012·4 cites·19 claims
- 2976US8114637B2Packaging cells for recombinant adenovirusVOGELS RONALD·Filed 2010·Granted Feb 14, 2012·2 cites·7 claims
- 3075US8609402B2Multivalent vaccines comprising recombinant viral vectorsHAVENGA MENZO JANS EMCO·Filed 2011·Granted Dec 17, 2013·1 cites·18 claims
- 3172US8221971B2Serotype of adenovirus and uses thereofBOUT ABRAHAM·Filed 2007·Granted Jul 17, 2012·1 cites·6 claims
- 3266US2008199433A1Complementing cell linesCRUCELL HOLLAND BV·Filed 2007·Application pending·0 cites
- 3366US2008153083A1Settings for recombinant adenoviral-based vaccinesCRUCELL HOLLAND BV·Filed 2007·Application pending·0 cites
- 3465US6929946B1Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cellsCRUCELL HOLLAND BV·Filed 1999·Granted Aug 16, 2005·12 cites·6 claims
- 3563US2005169891A1Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cellsFiled 2004·Application pending·0 cites
- 3663US2013156736A1Complementing cell linesVOGELS RONALD·Filed 2012·Application pending·0 cites
- 3762US2006104953A1Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereofHAVENGA MENZO·Filed 2006·Application pending·0 cites
- 3861US2004142472A1Gene delivery vectors with cell type specificity for primary human chondrocytesFiled 2004·Application pending·0 cites
- 3957US2003073072A1Chimeric adenovirusesFiled 2001·Application pending·0 cites
- 4056US2003138955A1Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereofFiled 2002·Application pending·0 cites
- 4152US2004043489A1Gene delivery vectors provided with a tissue tropism for dendritic cells and methods of useFiled 2003·Application pending·0 cites
- 4251US2022372515A1Adenovirus vectors and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2020·Application pending·0 cites
- 4349US6498027B1Targeted delivery through a cationic amino acid transporterINTROGENE BV·Filed 1999·Granted Dec 24, 2002·13 cites·12 claims
- 4449US2005181507A1Gene delivery vectors with cell type specificity for mesenchymal stem cellsFiled 2005·Application pending·0 cites
- 4548US2010143302A1Recombinant Adenoviruses Based on Serotype 26 and 48, and Use ThereofCRUCELL HOLLAND BV·Filed 2007·Application pending·0 cites
- 4648US2004115620A1Adenoviral repliconsFiled 2001·Application pending·0 cites
- 4748US2009110695A1Compositions Comprising a Recombinant Adenovirus and an AdjuvantHAVENGA MENZO JANS EMKO·Filed 2007·Application pending·0 cites
- 4847US2003096415A1Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR)Filed 2002·Application pending·0 cites
- 4946US2004033605A1Gene delivery vectors provided with a tissue tropism for dendritic cellsFiled 2001·Application pending·0 cites
- 5045US2003166287A1Targeted delivery through a cationic amino acid transporterFiled 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →